Skip to content

Clinical Outcome Measure at Stryker Spine

Clinical Outcome Measure at Stryker Spine: COMPASS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06226272
Acronym
COMPASS
Enrollment
5222
Registered
2024-01-26
Start date
2025-01-28
Completion date
2032-01-29
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease, Degenerative Scoliosis

Keywords

Device: Cervical or Thoracolumbar Spinal fusion, Device: Adult Spinal Deformities

Brief summary

This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).

Detailed description

Stryker Spine has a broad portfolio of spinal devices used to stabilize the spine. This PMCF study is designed to collect data on the performance and safety of the devices over their lifetime of 24 months post-implantation. Four protocols have been designed to aid in this process, a master and three sub-protocols. The sub-protocols are based on body region and indication: * S-S-102-A Cervical: Interbody Devices (IBDs), Vertebral Body Replacement Devices (VBRs), Internal Fixation Devices, and Vitoss * S-S-102-B Thoracolumbar: IBDs, VBRs, Internal Fixation Devices, and Vitoss * S-S-102-C Adult Spinal Deformities: IBDs, Internal Fixation Devices, and Vitoss Each of the sub-protocols has its own specific performance endpoint and hypothesis, radiographical data assessments, and SAPs. Safety data will be collected throughout the study.

Interventions

DEVICESpinal Fusion

Cervical Spinal Fusion

DEVICESpinal Deformities Correction

Spinal Deformities Correction

Sponsors

VB Spine, LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

Exclusion criteria

• The

Design outcomes

Primary

MeasureTime frameDescription
S-S-102-ABaseline through 24-months post-op.Mean change in the subject's Neck Disability Index (NDI) score.
S-S-102-BBaseline through 24-months post-op.Mean change in the subject's Oswestry Disability Index (ODI) score.
S-S-102-CBaseline through 24-months post-op.Mean change in the subject's Scoliosis Research Society-22 revised (SRS-22r).

Secondary

MeasureTime frameDescription
S-S-102-ASurgery through 24-months post-op.The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries
S-S-102-BSurgery through 24-months post-op.The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries
S-S-102-CSurgery through 24-months post-op.The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries

Countries

United States

Contacts

CONTACTMary Majer
mary.majer@vbspineco.com866-526-4171
CONTACTEffa Gyamfi
effa.gyamfi@vbspineco.com866-526-4171
PRINCIPAL_INVESTIGATORJad G. Khalil, MD

Michigan Orthopaedic Surgeons

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026